Lewiecki EM, Miller PD, McClung MR. et al. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of
postmenopausal women with low BMD. J Bone Miner Res 2007; 22: 1832-1841
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.